• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Crude Oil Moves Higher; Vera Bradley Shares Slide

    6/12/24 2:38:59 PM ET
    $BMR
    $DDC
    $RNA
    $THMO
    Computer Software: Prepackaged Software
    Technology
    Packaged Foods
    Consumer Staples
    Get the next $BMR alert in real time by email

    U.S. stocks traded higher toward the end of trading, with the S&P 500 surging around 1% on Wednesday.

    The Dow traded up 0.06% to 38,771.21 while the NASDAQ rose 1.77% to 17,651.35. The S&P 500 also rose, gaining, 1.03% to 5,430.69.

    Check This Out: General Motors, Toll Brothers And 2 Other Stocks Insiders Are Selling

    Leading and Lagging Sectors

    Information technology shares jumped by 3% on Wednesday.

    In trading on Wednesday, consumer staples shares fell by 1%.

    Top Headline

    The EIA said stocks of crude oil in the U.S. climbed by 3.730 million barrels in the week ending June 7, versus market expectations for a 1.55 million barrels decline.

    Equities Trading UP
                           

    • DDC Enterprise Limited (NYSE:DDC) shares shot up 241% to $1.75. DDC Enterprise said it has acquired beloved Asian food brand, Omsom.
    • Shares of Beamr Imaging Ltd. (NASDAQ:BMR) got a boost, surging 27% to $5.57 after the company announced that its Beamr Cloud solution has achieved Powered by Expertise and is now available in the Oracle Cloud Marketplace.
    • Avidity Biosciences, Inc. (NASDAQ:RNA) shares were also up, gaining 29% to $37.19 after the company announced initial AOC 1020 data from the Phase 1/2 FORTITUDE trial demonstrating reductions of greater than 50% in DUX4 regulated genes, trends of functional improvement, and favorable safety and tolerability in people living with facioscapulohumeral muscular dystrophy.

    Equities Trading DOWN

    • Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) shares dropped 48% to $1.10. Tonix Pharmaceuticals priced its $4 million public offering of 3,753,558 shares of common stock at $1.065 per share.
    • Shares of ThermoGenesis Holdings, Inc. (NASDAQ:THMO) were down 25% to $0.4021 after the Nasdaq denied the company's request for continued listing and the stock will be suspended at the opening of business on June 17.
    • Vera Bradley, Inc. (NASDAQ:VRA) was down, falling 17% to $6.41 following a first-quarter revenue miss and weak FY25 guidance.

    Also Check This Out: Uber To Rally Around 38%? Here Are 10 Top Analyst Forecasts For Wednesday

    Commodities

    In commodity news, oil traded up 0.7% to $78.48 while gold traded up 0.8% at $2,345.60.

    Silver traded up 2.1% to $29.85 on Wednesday, while copper rose 0.8% to $4.5450.

    Euro zone

    European shares closed higher today. The eurozone's STOXX 600 gained 1.08%, Germany's DAX gained 1.42% and France's CAC 40 rose 0.97%. Spain's IBEX 35 Index rose 0.63%, while London's FTSE 100 rose 0.83%.

    German consumer price inflation increased to 2.4% in May from a three-year low of 2.2% in the prior month.

    The UK’s trade deficit increased to around two-year high of £6.75 billion in April, while British economy stalled during April following a 0.4% expansion in March. Industrial production in the UK fell 0.9% month-over-month for April.

    Asia Pacific Markets

    Asian markets closed mixed on Wednesday, with Japan's Nikkei falling 0.66%, Hong Kong's Hang Seng Index falling 1.31%, China's Shanghai Composite Index gaining 0.31% and India's S&P BSE Sensex gaining 0.20%.

    Total passenger vehicle sales in India rose 4.3% year-over-year to 300,795 in May following a 1.2% gain in the prior month. Producer prices in Japan rose 2.4% year-over-year in May compared to a revised 1.1% increase in April.

    Chinese annual inflation rate came in at 0.3% in May versus market estimates of 0.4%, while producer prices fell by 1.4% year-over-year in May.

    Economics

    • The annual CPI inflation rate fell from 3.4% to 3.3% in May, below than the median economist projection of 3.4%. According to Econoday, the economist consensus ranged from 3.3% to 3.5%.
    • On a monthly basis, the overall CPI inflation stalled, decelerating from the prior 0.3% growth and coming in below expectations of 0.1%.
    • The EIA said stocks of crude oil in the U.S. climbed by 3.730 million barrels in the week ending June 7, versus market expectations for a 1.55 million barrels decline.

    Now Read This: Top 2 Utilities Stocks That May Rocket Higher In June

    Get the next $BMR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BMR
    $DDC
    $RNA
    $THMO

    CompanyDatePrice TargetRatingAnalyst
    Avidity Biosciences Inc.
    $RNA
    9/17/2025$62.00Buy
    Roth Capital
    Avidity Biosciences Inc.
    $RNA
    7/10/2025$55.00Buy
    Goldman
    Avidity Biosciences Inc.
    $RNA
    6/24/2025$50.00Outperform
    Bernstein
    Avidity Biosciences Inc.
    $RNA
    6/17/2025$55.00Outperform
    Wolfe Research
    Avidity Biosciences Inc.
    $RNA
    6/11/2025$65.00Strong Buy
    Raymond James
    Avidity Biosciences Inc.
    $RNA
    3/13/2025$70.00Buy
    Citigroup
    Avidity Biosciences Inc.
    $RNA
    3/12/2025$72.00Outperform
    BMO Capital Markets
    Avidity Biosciences Inc.
    $RNA
    3/7/2025$70.00Sector Outperform
    Scotiabank
    More analyst ratings

    $BMR
    $DDC
    $RNA
    $THMO
    SEC Filings

    View All

    SEC Form DEFA14A filed by Avidity Biosciences Inc.

    DEFA14A - Avidity Biosciences, Inc. (0001599901) (Filer)

    2/18/26 8:51:12 AM ET
    $RNA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Vera Bradley Inc.

    SCHEDULE 13G/A - Vera Bradley, Inc. (0001495320) (Subject)

    2/17/26 3:50:22 PM ET
    $VRA
    Apparel
    Consumer Discretionary

    Amendment: SEC Form SCHEDULE 13G/A filed by Avidity Biosciences Inc.

    SCHEDULE 13G/A - Avidity Biosciences, Inc. (0001599901) (Subject)

    2/17/26 12:31:43 PM ET
    $RNA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BMR
    $DDC
    $RNA
    $THMO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Saenger Bradley was granted 701 shares (SEC Form 5)

    5 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)

    2/17/26 7:00:19 AM ET
    $TNXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Medical Officer Hughes Steven George sold $354,643 worth of shares (4,895 units at $72.45), decreasing direct ownership by 13% to 31,599 units (SEC Form 4)

    4 - Avidity Biosciences, Inc. (0001599901) (Issuer)

    1/23/26 5:34:07 PM ET
    $RNA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President and CEO Boyce Sarah sold $1,042,338 worth of shares (14,387 units at $72.45), decreasing direct ownership by 5% to 269,007 units (SEC Form 4)

    4 - Avidity Biosciences, Inc. (0001599901) (Issuer)

    1/23/26 5:34:02 PM ET
    $RNA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BMR
    $DDC
    $RNA
    $THMO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Roth Capital initiated coverage on Avidity Biosciences with a new price target

    Roth Capital initiated coverage of Avidity Biosciences with a rating of Buy and set a new price target of $62.00

    9/17/25 7:57:56 AM ET
    $RNA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Goldman resumed coverage on Avidity Biosciences with a new price target

    Goldman resumed coverage of Avidity Biosciences with a rating of Buy and set a new price target of $55.00

    7/10/25 8:52:40 AM ET
    $RNA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Bernstein initiated coverage on Avidity Biosciences with a new price target

    Bernstein initiated coverage of Avidity Biosciences with a rating of Outperform and set a new price target of $50.00

    6/24/25 7:59:27 AM ET
    $RNA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BMR
    $DDC
    $RNA
    $THMO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Bickley Ian was granted 461,538 shares and bought $103,032 worth of shares (53,000 units at $1.94), increasing direct ownership by 157% to 841,629 units (SEC Form 4)

    4 - Vera Bradley, Inc. (0001495320) (Issuer)

    12/15/25 5:05:06 PM ET
    $VRA
    Apparel
    Consumer Discretionary

    Director Meslow Andrew bought $590,205 worth of shares (300,000 units at $1.97), increasing direct ownership by 100% to 600,000 units (SEC Form 4)

    4 - Vera Bradley, Inc. (0001495320) (Issuer)

    12/15/25 5:05:08 PM ET
    $VRA
    Apparel
    Consumer Discretionary

    Director Taylor Carolyn E. bought $15,061 worth of shares (418 units at $36.03) (SEC Form 4)

    4 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)

    8/21/25 5:22:56 PM ET
    $TNXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BMR
    $DDC
    $RNA
    $THMO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    The New England Journal of Medicine Publishes Results from Phase 1/2 MARINA® Trial of Delpacibart Etedesiran (del-desiran) for Treatment of Myotonic Dystrophy Type 1

    Del-desiran effectively delivered siRNA to muscle, resulting in approximately 40% mean reduction in DMPK mRNA and amelioration of missplicingTreatment demonstrated improvements in multiple measures including myotonia, muscle function and strength, mobility and patient-reported outcomesDel-desiran showed acceptable safety and tolerability with most adverse events mild or moderateSAN DIEGO, Feb. 18, 2026 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that the final results from the completed Phase 1/2 MARINA® trial of delpacibart eted

    2/18/26 5:00:00 PM ET
    $RNA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    DDC Surpasses 2,000 Bitcoin in Treasury Holdings with Additional 80 BTC Purchase

    DDC Enterprise Limited (NYSEAMERICAN: DDC) ("DDC" or the "Company"), a global Asian food platform and digital asset treasury company, today announced the acquisition of an additional 80 Bitcoin ("BTC"), bringing its corporate treasury to 2,068 BTC. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260217100155/en/DDC Now Holds 2,068 BTC The latest purchase marks DDC's sixth consecutive week of Bitcoin accumulation and represents a 74.8% increase in holdings since the start of 2026, reinforcing BTC's role as a foundational component of the Company corporate treasury strategy. The transaction was executed under DDC's established ca

    2/17/26 8:00:00 AM ET
    $DDC
    Packaged Foods
    Consumer Staples

    DDC Extends Bitcoin Accumulation Program into Fifth Consecutive Week

    DDC Enterprise Limited (NYSEAMERICAN: DDC) ("DDC" or the "Company"), a global Asian food platform and digital asset treasury company, today announced the acquisition of 100 Bitcoin ("BTC"). This latest purchase marks the fifth consecutive week of BTC acquisitions and brings the Company's total Bitcoin holdings to 1988. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260211709632/en/DDC Now Holds 1,988 BTC The transaction was executed following a recent pullback in BTC prices. The Company's activity remains guided by its established treasury parameters, with an emphasis on position sizing, liquidity, and balance sheet strength rat

    2/11/26 8:12:00 AM ET
    $DDC
    Packaged Foods
    Consumer Staples

    $BMR
    $DDC
    $RNA
    $THMO
    Leadership Updates

    Live Leadership Updates

    View All

    Tonix Pharmaceuticals Appoints Irina Ishak as General Counsel

    CHATHAM, N.J., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) ("Tonix" or the "Company"), a fully integrated commercial-stage biotechnology company today announced the appointment of Irina Ishak as General Counsel, effective December 8, 2025. Ms. Ishak will lead Tonix's legal, corporate governance, and compliance functions. "Irina is a highly accomplished corporate and commercial attorney whose experience spans public and private life sciences companies, as well as advising life sciences investors," said Seth Lederman, M.D., President and Chief Executive Officer of Tonix. "Her deep background in complex transactions, public company matters, and governa

    12/9/25 7:00:00 AM ET
    $TNXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Vera Bradley Announces Appointment of Ivan Brockman to Its Board of Directors

    FORT WAYNE, Ind., Nov. 21, 2025 (GLOBE NEWSWIRE) -- Vera Bradley, Inc. ("Vera Bradley" or the "Company") (NASDAQ:VRA) today announced the appointment of Ivan Brockman to its Board of Directors effective November 17, 2025. "We are pleased to welcome Ivan to the Vera Bradley Board of Directors," said Ian Bickley, Executive Chairman of the Company. "Ivan brings three decades of experience advising senior management teams, Board of Directors, and investors on strategic decision-making across all stages and cycles of growth and value creation for companies." Mr. Brockman currently serves as a Senior Advisor to PJT Partners, a leading independent investment bank, and previously was a Partner a

    11/21/25 8:05:00 AM ET
    $VRA
    Apparel
    Consumer Discretionary

    Tonix Pharmaceuticals Reports Third Quarter 2025 Financial Results and Operational Highlights

    Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the treatment of fibromyalgia set to launch in November Tonmya is the first new FDA-approved medicine for fibromyalgia in more than 15 years Cash and cash equivalents of $190.1 million reported as of September 30, 2025; current cash runway expected to fund operations into the first quarter of 2027 CHATHAM, N.J., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) ("Tonix" or the "Company"), a fully-integrated commercial biotechnology company today announced financial results for the third quarter ended September 30, 2025, and provided an overview of recent operational highlights. "Following U.S. Food a

    11/10/25 4:15:00 PM ET
    $TNXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BMR
    $DDC
    $RNA
    $THMO
    Financials

    Live finance-specific insights

    View All

    DDC Surpasses 2,000 Bitcoin in Treasury Holdings with Additional 80 BTC Purchase

    DDC Enterprise Limited (NYSEAMERICAN: DDC) ("DDC" or the "Company"), a global Asian food platform and digital asset treasury company, today announced the acquisition of an additional 80 Bitcoin ("BTC"), bringing its corporate treasury to 2,068 BTC. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260217100155/en/DDC Now Holds 2,068 BTC The latest purchase marks DDC's sixth consecutive week of Bitcoin accumulation and represents a 74.8% increase in holdings since the start of 2026, reinforcing BTC's role as a foundational component of the Company corporate treasury strategy. The transaction was executed under DDC's established ca

    2/17/26 8:00:00 AM ET
    $DDC
    Packaged Foods
    Consumer Staples

    DDC Extends Bitcoin Accumulation Program into Fifth Consecutive Week

    DDC Enterprise Limited (NYSEAMERICAN: DDC) ("DDC" or the "Company"), a global Asian food platform and digital asset treasury company, today announced the acquisition of 100 Bitcoin ("BTC"). This latest purchase marks the fifth consecutive week of BTC acquisitions and brings the Company's total Bitcoin holdings to 1988. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260211709632/en/DDC Now Holds 1,988 BTC The transaction was executed following a recent pullback in BTC prices. The Company's activity remains guided by its established treasury parameters, with an emphasis on position sizing, liquidity, and balance sheet strength rat

    2/11/26 8:12:00 AM ET
    $DDC
    Packaged Foods
    Consumer Staples

    DDC Extends Fourth Consecutive Week of Bitcoin Accumulation with Additional 105 BTC Purchase

    DDC Enterprise Limited (NYSEAMERICAN: DDC) ("DDC" or the "Company"), a global Asian food platform and digital asset treasury company, today announced the acquisition of 105 Bitcoin (BTC). This marks DDC's fourth consecutive week of Bitcoin purchases under the Company's structured accumulation program, and brings its total holdings to 1,888. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260205005228/en/DDC acquired additional 105 BTC DDC continues to view Bitcoin as a strategic reserve asset with long-duration characteristics that complement its broader capital structure. The Company's treasury framework emphasizes continuity of

    2/5/26 8:00:00 AM ET
    $DDC
    Packaged Foods
    Consumer Staples

    $BMR
    $DDC
    $RNA
    $THMO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Avidity Biosciences Inc.

    SC 13G/A - Avidity Biosciences, Inc. (0001599901) (Subject)

    11/14/24 5:46:11 PM ET
    $RNA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Tonix Pharmaceuticals Holding Corp.

    SC 13G/A - Tonix Pharmaceuticals Holding Corp. (0001430306) (Subject)

    11/14/24 4:42:22 PM ET
    $TNXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Tonix Pharmaceuticals Holding Corp.

    SC 13G/A - Tonix Pharmaceuticals Holding Corp. (0001430306) (Subject)

    11/14/24 4:40:17 PM ET
    $TNXP
    Biotechnology: Pharmaceutical Preparations
    Health Care